Liquid Biopsy for Cancer Detection: Clinical and Epidemiologic Considerations

Abstract Detection of circulating nucleic acids, also referred to as liquid biopsy, has been evaluated for detection of cancer in a variety of settings. We describe important clinical and epidemiologic considerations for liquid biopsy applications in cancer early detection and for monitoring of cancer recurrence. See related article by Jeannot et al., p. 5869